Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Lukasova, M
Title
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.
Citation
The Journal of Clinical Investigation; 2011 Mar; 121(3) pg1163-73
PubMed ID
21317532
Show Usages
Product Cited
Cross-Reactivity
Applications
400-20
Mouse
in vitro
First Author
Lauterbach, H
Title
Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.
Citation
The Journal of Experimental Medicine; 2010 Nov 22; 207(12) pg2703-17
PubMed ID
20975040
Show Usages
Product Cited
Cross-Reactivity
Applications
200-03
Human
in vitro
300-02
Human
in vitro
300-03
Human
in vitro
213-13
Mouse
in vitro
214-14
Mouse
in vitro
400-20
Mouse
in vitro
First Author
O'Keeffe, M
Title
Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals.
Citation
Blood; 2005 Nov 15; 106(10) pg3457-64
PubMed ID
16037393
Show Usages
Product Cited
Cross-Reactivity
Applications
400-20
Mouse
in vitro
First Author
O'Keeffe, M
Title
Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus.
Citation
The Journal of Experimental Medicine; 2002 Nov 18; 196(10) pg1307-19
PubMed ID
12438422
Show Usages
Product Cited
Cross-Reactivity
Applications
400-20
Mouse
in vitro
First Author
O'Keeffe, M
Title
Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors.
Citation
Blood; 2003 Feb 15; 101(4) pg1453-9
PubMed ID
12393665
Show Usages
Product Cited
Cross-Reactivity
Applications
400-20
Mouse
in vitro
showing 5 of 5